ACE and non-ACE mediated effect of angiotensin I on intracellular calcium mobilization in rat glomerular arterioles

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 6 53-6, 2003, Pages

  Marchetti, Jeannine ^a   Helou, Claudia M B ^a   Chollet, Catherine ^a   Rajerison, Rabary ^a   Alhenc Gelas, François ^a  

^a INSERM   (France)

Author keywords

Angiotensin I converting enzyme; Calcium signaling

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN I; APROTININ; CALCIUM; CHYMOSTATIN; DIPEPTIDYL CARBOXYPEPTIDASE; LEUPEPTIN; LISINOPRIL; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; RENIN;

ANIMAL TISSUE; ARTERIOLE; ARTICLE; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CONTROLLED STUDY; GLOMERULUS; HEMODYNAMICS; KIDNEY CIRCULATION; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

EID: 0037686698     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00042.2003     Document Type: Article

References (30)

1. Akasu M, Urata H, Kinoshita A, Sasaguri M, Ideishi M, and Arakawa K. Differences in tissue angiotensin II-forming pathways by species and organs in vitro. Hypertension 32: 514-520, 1998.
2. Allan DR, Hui KY, Coletti C, and Hollenberg NK. Renin vs. angiotensin converting enzyme inhibition in the rat: consequences for plasma and renal tissue angiotensin. J Pharmacol Exp Ther 283: 661-665, 1997.
3. Anderson S. Role of local and systemic angiotensin in diabetic renal disease. Kidney Int Suppl 63: S107-S110, 1997.
4. Anderson S, Jung FF, and Ingelfinger JR. Renal reninangiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am J Physiol Renal Fluid Electrolyte Physiol 265: F477-F486, 1993.
5. Arakawa K. Serine protease angiotensin II systems. J Hypertens 14: S3-S7, 1996.
6. Arnal JF, Battle T, Rasetti C, Challah C, Costerousse O, Vicaut E, Michel JB, and Alhenc-Gelas F. ACE in three tunicae of rat aorta: expression in smooth muscle and effect of renovascular hypertension. Am J Physiol Heart Circ Physiol 267: H1777-H1784, 1994.
7. Cadwell PR, Segal BC, Hsu KC, Das M, and Soffer RL. Angiotensin I converting enzyme: vascular endotheliellocalization. Science 191: 1050-1051, 1976.
8. Donoghue M, Hsieh F, Baronas E, Godhout K, Gosselin M, Stagliano N, Donavan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, and Acton S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts ang otensin I to angiotensin 1-9. Circ Res 87: El-E9, 2000.
9. Dzau VJ. Vascular renin-angiotensin: a possible autocrine or paracrine system in control of vascular function. J Cardiovasc Pharmacol 6: S377-S382, 1984.
10. Erdös EG. Angiotensin I converting enzyme and changes in our concepts through the years. Hypertension 16: 363-370, 1990.
11. i indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985.
12. Hackenthal E, Paul M, Ganten D, and Taugner R. Morphology, physiology, and molecular biology of renin secretion. Physiol Rev 70: 1067-1116, 1990.
13. Harris RC and Cheng HF. The intrarenal renin-angiotensin system: a paracrine system for the local control of renal function separate from the systemic axis. Exp Nephrol 4, Suppl 1: 2-7, 1996.
14. i responses to ANG II. Am J Physiol Renal Physiol 273: F84-F96, 1997.
15. i) in the glomerular arterioles: involvement of phenylalaninine residue in C terminal end (Abstract). J Am Soc Nephrol 11: p362A, 2000.
16. Itskovitz HD and Odya C. Intrarenal formation of angiotensin I. Science 174: 58-59, 1971.
17. Hollenberg NK. Implications of species difference for clinical investigation. Studies on the renin-angiotensin system. Hypertension 35: 150-155, 2000.
18. Johnston CI, Fabris B, and Jandeleit K. Intrarenal reninangiotensin system in renal physiology and pathophysiology. Kidney Int 44, Suppl 42: S59-S63, 1993.
19. Marchetti J, Meneton P, Lebrun F, Bloch-Faure M, and Rajerison RM. The parietal sheet of Bowman's capsule of rat renal glomerulus: a target of endothelin and PAF. Am J Physiol Renal Fluid Electrolyte Physiol 268: F1053-F1061, 1995.
20. i response to angiotensin II of renal juxtamedullary efferent arterioles via an EDHF. Br J Pharmacol 132: 749-759, 2001.
21. Misumi J, Gardes J, Gonzalez MF, Corvol P, and Menard J. Angiotensinogen's role in ANG formation, renin release, and renal hemodynamics in isolated perfused kidney. Am J Physiol Renal Fluid Electrolyte Physiol 256: F719-F727, 1989.
22. 2 receptor subtypes in the rat kidney. Am J Physiol Renal Physiol 277: F437-F446, 1999.
23. Navar LG, Inscho EW, Majid DSA, Imig JD, Harrison Bernard LM, and Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev 76: 425-536, 1996.
24. Petrov V, Fagard R, and Lijnen P. Effect of protease inhibitors on angiotensin-converting enzyme activity in human T-lymphocytes. Am J Hypertens 13: 535-539, 2000.
25. 2+ response to bradykinin in different types of juxtamedullary glomerular arterioles. Am J Physiol Renal Physiol 277: F697-F705, 1999.
26. Sasaguri M, Maeda H, Noda K, Tsuji E, Kinoshita A, Ideishi M, Ogata S, and Arakawa K. Purification and characterization of a kinin-and angiotensin II-forming enzyme in the dog heart. J Hypertens 15: 675-682, 1997.
27. Teursch B, Bihoreau C, Monnot C, Bernstein KE, Murphy TJ, Alexander RW, Corvol P, and Clauser E. A recombinant rat vascular AT1 receptor confers growth properties to angiotensin II in chinese hamster ovary cells. Biochem Biophys Res Commun 187: 1381-1388, 1992.
28. Turner AJ, Tipnis SR, Guy JL, Rice G, and Hooper NM. ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors. Can J Physiol Pharmacol 80: 346-353, 2002.
29. Urata H, Kinoshita A, Misono KS, Bumpus FM, and Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 265: 22348-22357, 1990.
30. Zimmerman BG and Dunham EW. Tissue renin-angiotensin system: a site of drug action? Annu Rev Pharmacol Toxicol 37: 53-69, 1997.